Allogene Therapeutics (ALLO) Stock Forecast for 2024–2028. Sell or Buy Prediction







Buy or Sell TSLA stocks? (TSLA) forecasting

Tesla: At A Crossroads

May 29, 2024
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Allogene Therapeutics (ALLO) Stock Forecast for 2024–2028. Sell or Buy?

Updated: May 30, 2024 (08:18)

Sector: Healthcare

The share price of Allogene Therapeutics, Inc. (ALLO) now

Latest session on the 29th of May for
Allogene Therapeutics, Inc. is negative
Trading Volume: 4088769
Open: 2.46 /  High: 2.54 /  Low: 2.32
What analysts predict: $11.55
52-week High/Low: $6.05 / $2.23

50/200 Day Moving Average: $3.476 / $3.513

This figure corresponds to the Average Price over the previous 50/200 days. For Allogene Therapeutics stocks, the 50-day moving average is the resistance level today.

For Allogene Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Allogene Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Allogene Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Allogene Therapeutics share be worth in 2024 - 2028?

When should I take profit in Allogene Therapeutics stock? When should I record a loss on Allogene Therapeutics stock? What are analysts' forecasts for Allogene Therapeutics stock? What is the future of Allogene Therapeutics stock? We forecast Allogene Therapeutics stock performance using neural networks based on historical data on Allogene Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Allogene Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Allogene Therapeutics shares. This happens once a day.


Historical and forecast chart of Allogene Therapeutics stock

The chart below shows the historical price of Allogene Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Allogene Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California.

Official site of the company

Allogene Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 01 2.52 2.41 2.59 7.25
Jun 02 2.57 2.45 2.69 9.60
Jun 03 2.40 2.29 2.51 9.61
Jun 04 2.33 2.27 2.36 4.39
Jun 05 2.48 2.39 2.58 7.91
Jun 06 2.45 2.32 2.53 9.01
Jun 07 2.41 2.29 2.52 10.40
Jun 08 2.33 2.29 2.44 6.77
Jun 09 2.21 2.17 2.31 6.42
Jun 10 2.18 2.06 2.21 7.48
Jun 11 2.04 1.93 2.13 10.04
Jun 12 2.06 2.03 2.14 5.61
Jun 13 2.03 1.94 2.14 10.18
Jun 14 2.07 2.04 2.15 5.40
Jun 15 2.04 1.95 2.09 7.19
Jun 16 2.02 1.96 2.12 8.23
Jun 17 1.97 1.94 2.08 6.89
Jun 18 1.90 1.80 2.01 11.71
Jun 19 1.91 1.85 1.98 6.65
Jun 20 1.90 1.81 1.96 8.07
Jun 21 1.96 1.89 2.07 9.36
Jun 22 1.83 1.79 1.88 5.00
Jun 23 1.91 1.86 1.96 5.54
Jun 24 2.03 1.97 2.07 5.18
Jun 25 2.13 2.06 2.21 7.08
Jun 26 2.12 2.07 2.20 6.09
Jun 27 2.07 2.01 2.10 4.68
Jun 28 2.11 2.08 2.18 4.83
Jun 29 2.12 2.01 2.22 10.65
Jun 30 2.07 1.96 2.11 7.66

Allogene Therapeutics Daily Price Targets


Allogene Therapeutics Stock Forecast 06-01-2024.

Forecast target price for 06-01-2024: $2.52.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 6.760%.
Pessimistic target level: 2.41
Optimistic target level: 2.59

Allogene Therapeutics Stock Forecast 06-02-2024.

Forecast target price for 06-02-2024: $2.57.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 8.759%.
Pessimistic target level: 2.45
Optimistic target level: 2.69

Allogene Therapeutics Stock Forecast 06-03-2024.

Forecast target price for 06-03-2024: $2.40.
Negative dynamics for Allogene Therapeutics shares will prevail with possible volatility of 8.765%.
Pessimistic target level: 2.29
Optimistic target level: 2.51

Allogene Therapeutics Stock Forecast 06-04-2024.

Forecast target price for 06-04-2024: $2.33.
Negative dynamics for Allogene Therapeutics shares will prevail with possible volatility of 4.202%.
Pessimistic target level: 2.27
Optimistic target level: 2.36

Allogene Therapeutics Stock Forecast 06-05-2024.

Forecast target price for 06-05-2024: $2.48.
Positive dynamics for Allogene Therapeutics shares will prevail with possible volatility of 7.332%.
Pessimistic target level: 2.39
Optimistic target level: 2.58

Allogene Therapeutics Stock Forecast 06-06-2024.

Forecast target price for 06-06-2024: $2.45.
Negative dynamics for Allogene Therapeutics shares will prevail with possible volatility of 8.268%.
Pessimistic target level: 2.32
Optimistic target level: 2.53

ALLO (ALLO) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jun. 2.58 2.42 2.72 11.01
Jul. 2.47 2.37 2.61 9.19
Aug. 2.58 2.48 2.76 10.11
Sep. 2.37 2.25 2.54 11.33
Oct. 2.27 2.14 2.35 8.70
Nov. 2.31 2.19 2.47 11.60
Dec. 2.30 2.14 2.45 12.68

Allogene Therapeutics forecast for this year


Allogene Therapeutics Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $2.58309. Pessimistic: $2.42. Optimistic: $2.72


Allogene Therapeutics Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $2.46943. Pessimistic: $2.37. Optimistic: $2.61


Allogene Therapeutics Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $2.58303. Pessimistic: $2.48. Optimistic: $2.76


Allogene Therapeutics Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $2.3738. Pessimistic: $2.25. Optimistic: $2.54


Allogene Therapeutics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $2.26698. Pessimistic: $2.14. Optimistic: $2.35


Allogene Therapeutics Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $2.31459. Pessimistic: $2.19. Optimistic: $2.47


Allogene Therapeutics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $2.30302. Pessimistic: $2.14. Optimistic: $2.45



Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 2.20 2.14 2.30 7.24
Mar 2.15 2.08 2.20 5.37
Mar 2.36 2.21 2.42 8.68
Apr 2.27 2.12 2.35 9.73
May 2.07 1.99 2.16 7.94
Jun 2.18 2.12 2.23 4.79
Jul 2.11 2.01 2.23 10.13
Aug 2.10 1.95 2.25 13.23
Sep 2.09 1.98 2.17 8.93
Oct 2.16 2.11 2.21 4.30
Nov 2.05 1.96 2.14 8.16
Dec 2.15 2.00 2.25 11.27

Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.06 1.95 2.20 11.42
Mar 1.95 1.83 2.01 8.99
Mar 1.89 1.82 2.03 10.17
Apr 1.88 1.83 1.98 7.23
May 1.87 1.80 1.94 7.12
Jun 1.79 1.72 1.85 7.05
Jul 1.78 1.67 1.89 12.02
Aug 1.79 1.72 1.86 7.68
Sep 1.85 1.71 1.99 13.79
Oct 1.95 1.86 2.08 10.92
Nov 1.79 1.73 1.86 7.40
Dec 1.74 1.66 1.78 7.23

Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 1.73 1.59 1.85 14.06
Mar 1.87 1.74 1.95 11.03
Mar 1.86 1.75 1.98 11.94
Apr 2.01 1.92 2.08 7.63
May 2.13 2.04 2.19 6.92
Jun 2.32 2.18 2.48 12.23
Jul 2.49 2.33 2.58 9.75
Aug 2.62 2.49 2.67 6.76
Sep 2.53 2.45 2.65 7.52
Oct 2.43 2.34 2.54 7.74
Nov 2.41 2.26 2.55 11.25
Dec 2.40 2.22 2.51 11.57

Allogene Therapeutics (ALLO) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 2.62 2.52 2.73 7.48
Feb 2.49 2.42 2.59 6.55
Mar 2.57 2.48 2.72 9.05
Apr 2.71 2.64 2.88 8.19
May 2.86 2.69 3.07 12.21
Jun 2.80 2.67 2.93 9.07
Jul 2.82 2.64 2.92 9.38
Aug 2.97 2.83 3.17 10.76
Sep 2.67 2.51 2.83 11.51
Oct 2.57 2.48 2.70 8.38
Nov 2.46 2.30 2.53 8.86
Dec 2.29 2.12 2.43 12.79

Allogene Therapeutics information and performance

Allogene Therapeutics Address

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Market Capitalization: 526 136 000 $

Market capitalization of the Allogene Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALLO shares in the company outstanding by the market price of one share.

EBITDA: -270 656 992 $

EBITDA of Allogene Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.78

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.267
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3041.83

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.962

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 208784000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.